Cargando…
Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus
“What's in a name? That which we call a rose / By any other name would smell as sweet” (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare's implication is that a name is nothing but a word and it therefore represents a convention with no intrinsic meaning. Whilst this may...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118767/ https://www.ncbi.nlm.nih.gov/pubmed/36219203 http://dx.doi.org/10.20945/2359-3997000000528 |
_version_ | 1785028870565527552 |
---|---|
author | Arima, Hiroshi Cheetham, Timothy Christ-Crain, Mirjam Cooper, Deborah L. Drummond, Juliana B. Gurnell, Mark Levy, Miles McCormack, Ann Newell-Price, John D. Verbalis, Joseph G. Wass, John |
author_facet | Arima, Hiroshi Cheetham, Timothy Christ-Crain, Mirjam Cooper, Deborah L. Drummond, Juliana B. Gurnell, Mark Levy, Miles McCormack, Ann Newell-Price, John D. Verbalis, Joseph G. Wass, John |
author_sort | Arima, Hiroshi |
collection | PubMed |
description | “What's in a name? That which we call a rose / By any other name would smell as sweet” (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare's implication is that a name is nothing but a word and it therefore represents a convention with no intrinsic meaning. Whilst this may be relevant to romantic literature, disease names do have real meanings, and consequences, in medicine. Hence, there must be a very good rational for changing the name of a disease that has a centuries-old historical context. A working group of representatives from national and international endocrinology and endocrine pediatric societies now proposes changing the name of “diabetes insipidus” to “Arginine Vasopressin Deficiency (AVP-D)” for central etiologies, and “Arginine Vasopressin Resistance (AVP-R)” for nephrogenic etiologies This editorial provides both the historical context and the rational for this proposed name change. |
format | Online Article Text |
id | pubmed-10118767 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Sociedade Brasileira de Endocrinologia e Metabologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-101187672023-04-21 Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus Arima, Hiroshi Cheetham, Timothy Christ-Crain, Mirjam Cooper, Deborah L. Drummond, Juliana B. Gurnell, Mark Levy, Miles McCormack, Ann Newell-Price, John D. Verbalis, Joseph G. Wass, John Arch Endocrinol Metab Position Statement “What's in a name? That which we call a rose / By any other name would smell as sweet” (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare's implication is that a name is nothing but a word and it therefore represents a convention with no intrinsic meaning. Whilst this may be relevant to romantic literature, disease names do have real meanings, and consequences, in medicine. Hence, there must be a very good rational for changing the name of a disease that has a centuries-old historical context. A working group of representatives from national and international endocrinology and endocrine pediatric societies now proposes changing the name of “diabetes insipidus” to “Arginine Vasopressin Deficiency (AVP-D)” for central etiologies, and “Arginine Vasopressin Resistance (AVP-R)” for nephrogenic etiologies This editorial provides both the historical context and the rational for this proposed name change. Sociedade Brasileira de Endocrinologia e Metabologia 2022-10-11 /pmc/articles/PMC10118767/ /pubmed/36219203 http://dx.doi.org/10.20945/2359-3997000000528 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Position Statement Arima, Hiroshi Cheetham, Timothy Christ-Crain, Mirjam Cooper, Deborah L. Drummond, Juliana B. Gurnell, Mark Levy, Miles McCormack, Ann Newell-Price, John D. Verbalis, Joseph G. Wass, John Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus |
title | Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus |
title_full | Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus |
title_fullStr | Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus |
title_full_unstemmed | Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus |
title_short | Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus |
title_sort | changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus |
topic | Position Statement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118767/ https://www.ncbi.nlm.nih.gov/pubmed/36219203 http://dx.doi.org/10.20945/2359-3997000000528 |
work_keys_str_mv | AT arimahiroshi changingthenameofdiabetesinsipidusapositionstatementoftheworkinggrouptoconsiderrenamingdiabetesinsipidus AT cheethamtimothy changingthenameofdiabetesinsipidusapositionstatementoftheworkinggrouptoconsiderrenamingdiabetesinsipidus AT christcrainmirjam changingthenameofdiabetesinsipidusapositionstatementoftheworkinggrouptoconsiderrenamingdiabetesinsipidus AT cooperdeborahl changingthenameofdiabetesinsipidusapositionstatementoftheworkinggrouptoconsiderrenamingdiabetesinsipidus AT drummondjulianab changingthenameofdiabetesinsipidusapositionstatementoftheworkinggrouptoconsiderrenamingdiabetesinsipidus AT gurnellmark changingthenameofdiabetesinsipidusapositionstatementoftheworkinggrouptoconsiderrenamingdiabetesinsipidus AT levymiles changingthenameofdiabetesinsipidusapositionstatementoftheworkinggrouptoconsiderrenamingdiabetesinsipidus AT mccormackann changingthenameofdiabetesinsipidusapositionstatementoftheworkinggrouptoconsiderrenamingdiabetesinsipidus AT newellpricejohnd changingthenameofdiabetesinsipidusapositionstatementoftheworkinggrouptoconsiderrenamingdiabetesinsipidus AT verbalisjosephg changingthenameofdiabetesinsipidusapositionstatementoftheworkinggrouptoconsiderrenamingdiabetesinsipidus AT wassjohn changingthenameofdiabetesinsipidusapositionstatementoftheworkinggrouptoconsiderrenamingdiabetesinsipidus |